KMT2A and acute myeloid leukemia: We also use signatures forPML-RARA gene fusions and MLL-fusions that were derived using pediatric AML samples but shown to work well for classifying adult AML samples with similar lesions14, although we note that there is evidence of relatively large differences in the mutational profiles of adult and pediatric cancers16.